Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Independent Bulletin homepage

Social Partner

We are 8 logo (opens in a new tab)

New blood test can detect cancers before symptoms appear

Using AI, scientists can detect cancers before symptoms appear with 99 per cent accuracy — Using AI, scientists can detect cancers before symptoms appear with 99 per cent accuracy (PA Wire)

A new blood test, miONCO-Dx, is being evaluated for use in the NHS. It can detect a dozen cancers, including bowel cancer, before symptoms appear.
The UK government is backing the next testing phase, aiming to improve early detection and survival rates.
The research will be conducted at the newly named BowelBabe Laboratory at the Francis Crick Institute, in honor of Dame Deborah James.
The miONCO-Dx test analyses microRNA in blood samples, using AI to identify and locate cancers with 99 per cent accuracy in initial tests.
A £2.4 million grant will support a trial involving 8,000 patients to gather evidence for NHS approval.

Pioneering new cancer trial to detect early symptoms to be conducted in Deborah James’ BowelBabe Laboratory — In full